{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:47:29Z","timestamp":1791557249516,"version":"4.3.4"},"reference-count":122,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"F2G"},{"name":"Pulmocide"},{"name":"Amplyx"},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"F2G"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cmi.2018.11.027","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T21:49:36Z","timestamp":1545342576000},"page":"799-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management"],"prefix":"10.1016","volume":"25","author":[{"given":"P.P.A.","family":"Lestrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.11.027_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2018.11.027_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.11.027_bib3","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.cmi.2017.04.012","article-title":"A\u00a0prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study","volume":"23","author":"Risslegger","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.11.027_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.11.027_bib5","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06822.x","article-title":"Current section and species complex concepts in Aspergillus: recommendations for routine daily practice","volume":"1273","author":"Alastruey-Izquierdo","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cmi.2018.11.027_bib8","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","author":"Van Der Linden","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.11.027_bib9","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/evo.12763","article-title":"Asexual sporulation facilitates adaptation: the emergence of azole resistance in Aspergillus fumigatus","volume":"69","author":"Zhang","year":"2015","journal-title":"Evolution"},{"key":"10.1016\/j.cmi.2018.11.027_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib12","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1473-3099(16)30138-4","article-title":"In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management","volume":"16","author":"Verweij","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib13","doi-asserted-by":"crossref","first-page":"e0193732","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"Bongomin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.11.027_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib15","doi-asserted-by":"crossref","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2018.11.027_bib16","doi-asserted-by":"crossref","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus","volume":"7","author":"Snelders","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.11.027_bib17","doi-asserted-by":"crossref","first-page":"e52871","DOI":"10.1371\/journal.pone.0052871","article-title":"Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\u2083\u2084\/L98H mutations in the cyp51A gene in India","volume":"7","author":"Chowdhary","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.11.027_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00791-17","article-title":"A\u00a0novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence","volume":"8","author":"Zhang","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2018.11.027_bib19","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1007\/s11356-018-3177-6","article-title":"Determination of azole fungal residues in soils and detection of Aspergillus fumigatus-resistant strains in market gardens of Eastern France","volume":"25","author":"Rocchi","year":"2018","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.cmi.2018.11.027_bib20","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole Resistance in Aspergillus fumigatus, the Netherlands 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect DIs"},{"key":"10.1016\/j.cmi.2018.11.027_bib21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A\u00a0new Aspergillus fumigatus resistance mechanism conferring in\u00a0vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1164\/rccm.201510-2104LE","article-title":"Voriconazole-susceptible and voriconazole-resistant Aspergillus fumigatus coinfection","volume":"193","author":"Kolwijck","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2018.11.027_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jac\/dku410","article-title":"Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures","volume":"70","author":"Ahmad","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib25","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/CMR.00095-16","article-title":"Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species","volume":"30","author":"Dudakova","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2018.11.027_bib27","doi-asserted-by":"crossref","first-page":"20150460","DOI":"10.1098\/rstb.2015.0460","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"371","author":"Meis","year":"2016","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.cmi.2018.11.027_bib28","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1128\/AAC.00606-10","article-title":"Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib29","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1128\/AAC.01111-13","article-title":"Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method","volume":"57","author":"Howard","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","article-title":"Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in the Netherlands","volume":"70","author":"van Ingen","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01928-17","article-title":"Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical Isolates from a chest hospital surveillance in Delhi, India","volume":"62","author":"Sharma","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/infdis\/jis442","article-title":"In\u00a0vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration","volume":"206","author":"Arendrup","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.00516","article-title":"Azole-resistance in Aspergillus terreus and related species: an emerging problem or a rare phenomenon?","volume":"9","author":"Zoran","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.11.027_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/myc.12440","article-title":"Diagnosis and management of aspergillosis in the Netherlands: a national survey","volume":"59","author":"Lestrade","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.11.027_bib36","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drup.2014.06.001","article-title":"The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside","volume":"17","author":"Seyedmousavi","year":"2014","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.cmi.2018.11.027_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01250-17","article-title":"Agar based screening for azole based screening for azole resistance in Aspergillus fumigatus using VIPcheck\u2122: a single centre evaluation","volume":"61","author":"Buil","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib39","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/jac\/dkx319","article-title":"Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus","volume":"72","author":"Arendrup","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fmicb.2018.00515","article-title":"Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples","volume":"9","author":"Buil","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib41","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay\u00ae in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"12","author":"Chong","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib42","first-page":"O0264","article-title":"Profiling Aspergillus fumigatus cyp51A polymorphisms by pyrosequencing reveals triazole resistance when susceptibility testing is not possible","author":"Novak-Frazer","year":"2018","journal-title":"ECCMID"},{"key":"10.1016\/j.cmi.2018.11.027_bib43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib44","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00233-15","article-title":"Nationwide surveillance of azole resistance in aspergillus diseases","volume":"59","author":"Vermeulen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-018-1170-0","article-title":"A\u00a0nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria","author":"Lass-Fl\u00f6rl","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2018.11.027_bib47","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3389\/fmicb.2018.01656","article-title":"Aspergillus species and antifungals susceptibility in clinical setting in the north of Portugal:cryptic species and emerging azoles resistance in A.\u00a0fumigatus","volume":"19","author":"Pinto","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib48","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/AAC.02234-15","article-title":"Azole resistance in Aspergillus fumigatus clinical isolates from an Italian culture collection","volume":"60","author":"Lazzarini","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib50","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02088-17","article-title":"Azole resistance of environmental and clinical Aspergillus fumigatus isolates from Switzerland","volume":"62","author":"Riat","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with TR34\/L98H mutations in the cyp51A gene in Iran","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.11.027_bib53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3201\/eid1905.130075","article-title":"Azole-resistant Aspergillus fumigatus, Iran","volume":"19","author":"Seyedmousavi","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3314\/mmj.17-00002","article-title":"Azole-resistant Aspergillus fumigatus containing a 34-bp tandem repeat in cyp51A promoter is isolated from the environment in Japan","volume":"58","author":"Onishi","year":"2017","journal-title":"Med Mycol J"},{"key":"10.1016\/j.cmi.2018.11.027_bib55","doi-asserted-by":"crossref","first-page":"45631","DOI":"10.1038\/srep45631","article-title":"Azole-resistant Aspergillus fumigatus harboring TR34\/L98H, TR46\/Y121F\/T289A and TR53 mutations related to flower fields in Colombia","volume":"7","author":"Alvarez-Moreno","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2018.11.027_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes","volume":"22","author":"Jensen","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.11.027_bib57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/myc.12354","article-title":"Azole-resistant Aspergillus fumigatus isolates carrying TR\u2083\u2084\/L98H mutations in Taiwan","volume":"58","author":"Wu","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.11.027_bib58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/cix297","article-title":"Changes in in\u00a0vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary are cancer center, 1999\u20132015","volume":"65","author":"Heo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib59","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/JCM.01582-14","article-title":"Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in\u00a0vitro susceptibility to triazoles","volume":"52","author":"Negri","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2016.10.019","article-title":"Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study","volume":"49","author":"Koehler","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.11.027_bib61","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"Cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib62","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/mmy\/myx012","article-title":"Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles","volume":"56","author":"Nawrot","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.11.027_bib64","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fmicb.2018.01395","article-title":"Determination of the prevalence of triazole resistance in environmental Aspergillus fumigatus strains isolated in South Wales, UK","volume":"9","author":"Tsitsopoulou","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib65","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/AAC.00100-15","article-title":"Environmental isolates of azole-resistant Aspergillus fumigatus in Germany","volume":"59","author":"Bader","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib66","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib67","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00127-15","article-title":"First description of azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation in France","volume":"59","author":"Lavergne","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib68","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jiac.2015.04.012","article-title":"First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34\/L98H mutations in Turkey","volume":"21","author":"\u00d6zmerdiven","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib69","first-page":"5","article-title":"Global aspects of triazole resistance in Aspergillus fumigatus with focus on Latin American countries","volume":"3","author":"Gon\u00e7alves","year":"2017","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.cmi.2018.11.027_bib70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bjid.2017.10.005","article-title":"In\u00a0vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil","volume":"22","author":"Bedin Denardi","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib71","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/AAC.02487-12","article-title":"Is azole resistance in Aspergillus fumigatus a problem in Spain?","volume":"57","author":"Escribano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib72","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib74","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkq450","article-title":"Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies","volume":"66","author":"Alanio","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib76","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.11.027_bib77","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1128\/AAC.01491-10","article-title":"Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece","volume":"55","author":"Arabatzis","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib78","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/myc.12770","article-title":"Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation","volume":"61","author":"Talento","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.11.027_bib80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1462-2920.13988","article-title":"Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan","volume":"20","author":"Wang","year":"2018","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib81","article-title":"Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in Pakistan","volume":"7","author":"Perveen","year":"2016","journal-title":"Adv Against Aspergillosis Conf"},{"key":"10.1016\/j.cmi.2018.11.027_bib82","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11046-018-0271-8","article-title":"TR34\/L98H mutation in CYP51A gene in Aspergillus fumigatus clinical isolates during posaconazole prophylaxis: first case in Korea","volume":"183","author":"Lee","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2018.11.027_bib83","doi-asserted-by":"crossref","first-page":"7147938","DOI":"10.1155\/2018\/7147938","article-title":"Triazole-resistant Aspergillus fumigatus from fungicide-experienced soils in naivasha subcounty and Nairobi county, Kenya","volume":"2018","author":"Kemoi","year":"2018","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgar.2015.01.005","article-title":"Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: is it de novo or environmentally acquired?","volume":"3","author":"Sharma","year":"2015","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2018.11.027_bib85","first-page":"429","article-title":"Prevalence of azole-resistant Aspergillus fumigatus in the environment of Thailand","volume":"55","author":"Tangwattanachuleeporn","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.11.027_bib86","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/jac\/dkx168","article-title":"Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA","author":"Hurst","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib87","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/emi.2017.97","article-title":"Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China","volume":"6","author":"Deng","year":"2017","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.cmi.2018.11.027_bib88","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/AAC.00003-15","article-title":"Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China","volume":"59","author":"Liu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00872-18","article-title":"First clinical isolation of an azole-resistant Aspergillus fumigatus harboring a TR46\/Y121F\/T289A mutation in South America","volume":"62","author":"Isla","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhazmat.2016.12.013","article-title":"Fungicides induced triazole-resistance in Aspergillus fumigatus associated with mutations of TR46\/Y121F\/T289A and its appearance in agricultural fields","volume":"326","author":"Ren","year":"2017","journal-title":"J\u00a0Hazard Mater"},{"key":"10.1016\/j.cmi.2018.11.027_bib91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcf.2016.06.006","article-title":"Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy","volume":"16","author":"Prigitano","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cmi.2018.11.027_bib92","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/jac\/dky187","article-title":"Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates","volume":"73","author":"Talbot","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib93","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.envres.2014.05.009","article-title":"Occurrence of triazole-resistant Aspergillus fumigatus with TR34\/L98H mutations in outdoor and hospital environment in Kuwait","volume":"133","author":"Ahmad","year":"2014","journal-title":"Environ Res"},{"key":"10.1016\/j.cmi.2018.11.027_bib94","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the transplant-associated infection surveillance network","volume":"47","author":"Baddley","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib95","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12879-016-1796-4","article-title":"Aspergillus fumigatus carrying TR34\/L98H resistance allele causing complicated suppurative otitis media in Tanzania: call for improved diagnosis of fungi in sub-Saharan Africa","volume":"16","author":"Mushi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib96","doi-asserted-by":"crossref","first-page":"20326","DOI":"10.2807\/ese.17.48.20326-en","article-title":"Azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation emerging in Belgium, July 2012","volume":"17","author":"Vermeulen","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2018.11.027_bib97","doi-asserted-by":"crossref","first-page":"20747","DOI":"10.2807\/1560-7917.ES2014.19.12.20747","article-title":"Azole-resistant Aspergillus fumigatus in the environment of northern Italy, May 2011 to June 2012","volume":"19","author":"Prigitano","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2018.11.027_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2018.08.004","article-title":"High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardio-thoracic centre","author":"Abdolrasouli","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.11.027_bib99","doi-asserted-by":"crossref","first-page":"e02400","DOI":"10.1128\/AAC.02240-17","article-title":"Detection of TR34\/L98H CYP51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the United States from 2015 to 2017","volume":"62","author":"Berkow","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib101","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myv029","article-title":"Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France","volume":"53","author":"Choukri","year":"2015","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.11.027_bib102","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ina.12436","article-title":"Emergence of Aspergillus fumigatus azole resistance in azole-na\u00efve patients with chronic obstructive pulmonary disease and their homes","volume":"28","author":"Dauchy","year":"2018","journal-title":"Indoor Air"},{"key":"10.1016\/j.cmi.2018.11.027_bib103","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fmicb.2018.00531","article-title":"Performance of molecular approaches for Aspergillus detection and azole resistance surveillance in cystic fibrosis","volume":"9","author":"Guegan","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib104","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/cid\/ciw664","article-title":"Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients","volume":"64","author":"Lavergne","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib105","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/jac\/dks160","article-title":"High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR\/L98H, in a French cohort of patients with cystic fibrosis","volume":"67","author":"Morio","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib106","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/jac\/dky147","article-title":"Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany","volume":"73","author":"Seufert","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhin.2018.07.030","article-title":"Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital area and patient risk determination for invasive aspergillosis including azole resistance","author":"Wirmann","year":"2018","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2018.11.027_bib108","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/mmy\/myx144","article-title":"Triazole resistance surveillance in Aspergillus fumigatus","volume":"56","author":"Sharpe","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.11.027_bib109","unstructured":"NethMap 2018: Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Available at: https:\/\/www.rivm.nl\/Documenten_en_publicaties\/Wetenschappelijk\/Rapporten\/2018\/Juni\/NethMap_2018_Consumption_of_antimicrobial_agents_and_antimicrobial_resistance_among_medically_important_bacteria_in_the_Netherlands_MARAN_2018_Monitoring_of_Antimicrobial_Resistance_and_Antibiotic_Usage_in_Animals_in_the_Netherlands_in_2017."},{"key":"10.1016\/j.cmi.2018.11.027_bib110","first-page":"20","article-title":"Antifungal susceptibility of respiratory Aspergillus Isolates from Canadian hospitals: results of the Canward 2013 Study","volume":"25","author":"Fuller","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.cmi.2018.11.027_bib111","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/jac\/dkw259","article-title":"Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?","volume":"71","author":"Verweij","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib112","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/jac\/dkw036","article-title":"New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?","volume":"71","author":"Alanio","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib113","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2018.11.027_bib114","article-title":"Single center trends in azole resistance in Aspergillus fumigatus over a 23-year period, 1994\u20132016","author":"Buil","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib115","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib116","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicentre retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.11.027_bib117","doi-asserted-by":"crossref","first-page":"30300","DOI":"10.2807\/1560-7917.ES.2016.21.30.30300","article-title":"Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","author":"van Paassen","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2018.11.027_bib118","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/jac\/dkx527","article-title":"Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study","volume":"73","author":"Lestrade","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib119","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"van de Veerdonk","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2018.11.027_bib120","first-page":"20262","article-title":"Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany","volume":"17","author":"Hamprecht","year":"2012","journal-title":"Euro Surveill Bull"},{"key":"10.1016\/j.cmi.2018.11.027_bib121","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/AAC.03850-14","article-title":"Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis","volume":"59","author":"Seyedmousavi","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.11.027_bib122","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/1462-2920.14055","article-title":"Emergence of azole resistant Aspergillus fumigatus and One Health: time to implement environmental stewardship","volume":"20","author":"Chowdhary","year":"2018","journal-title":"Environ Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18307808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18307808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:15:39Z","timestamp":1775326539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18307808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":122,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1198743X18307808"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.11.027","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}